Kovitz Investment Group Partners
VRTX icon

Kovitz Investment Group Partners’s Vertex Pharmaceuticals VRTX Stock Holding History

Kovitz Investment Group Partners’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47.3M Buy
95,246
+4,361
+5% +$1.93M 1.05% 19
2026
Q1 		$40.6M Sell
90,885
-7,490
-8% -$3.49M 0.94% 19
2025
Q4 		$44.6M Buy
98,375
+17,788
+22% +$7.67M 0.99% 17
2025
Q3 		$31.6M Buy
80,587
+48,544
+151% +$20.3M 0.12% 156
2025
Q2 		$14.3M Buy
32,043
+23,574
+278% +$10.9M 0.06% 245
2025
Q1 		$4.11M Sell
8,469
-8,712
-51% -$4.06M 0.02% 438
2024
Q4 		$6.92M Sell
17,181
-18,902
-52% -$8.76M 0.03% 335
2024
Q3 		$15.4M Buy
36,083
+4,638
+15% +$2.23M 0.11% 167
2024
Q2 		$14.7M Buy
31,445
+29,843
+1,863% +$13M 0.13% 123
2024
Q1 		$670K Buy
+1,602
New +$677K 0.01% 463
2022
Q1 		– Sell
-3,128
Closed -$739K – 465
2021
Q4 		$739K Sell
3,128
-6,110
-66% -$1.19M 0.02% 314
2021
Q3 		$1.68M Sell
9,238
-2,420
-21% -$472K 0.03% 246
2021
Q2 		$2.35M Buy
11,658
+6,040
+108% +$1.26M 0.05% 225
2021
Q1 		$1.21M Buy
5,618
+2,490
+80% +$547K 0.03% 265
2020
Q4 		$739K Sell
3,128
-1,610
-34% -$369K 0.02% 307
2020
Q3 		$1.29M Buy
+4,738
New +$1.31M 0.04% 237

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Kovitz Investment Group Partners's VRTX Position: Q2 2026 in Review

Kovitz Investment Group Partners increased its Vertex Pharmaceuticals (VRTX) stake by 4.8% in Q2 2026, buying an estimated $1.93M and bringing the position to 95,246 shares worth $47.3M. The position accounts for 1.05% of the portfolio, ranked #19.

Kovitz Investment Group Partners first reported a position in VRTX in Q3 2020 and has held it in 16 quarters since. 1,758 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Kovitz Investment Group Partners held 95,246 shares of Vertex Pharmaceuticals worth $47.3M as of Q2 2026.
  • Kovitz Investment Group Partners bought 4,361 Vertex Pharmaceuticals shares in Q2 2026, an estimated $1.93M.
  • Vertex Pharmaceuticals made up 1.05% of Kovitz Investment Group Partners's portfolio in Q2 2026, its #19 holding.
  • Kovitz Investment Group Partners first reported a position in Vertex Pharmaceuticals in Q3 2020 and has held it in 16 quarters since.
  • 1,758 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Kovitz Investment Group Partners's 13F filing for Q2 2026, filed 12 Aug 2026.